← Back to Search

Device

Portable Oxygen Concentrator for Nocturnal Hypoxemia

N/A
Waitlist Available
Research Sponsored by Inogen Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 hours overnight
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a portable oxygen machine to see if it can keep adults' oxygen levels stable while they sleep. The study focuses on people who need extra oxygen at night and checks if the device works well enough to maintain their oxygen levels.

Eligible Conditions
  • Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 hours overnight
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 hours overnight for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number/% of subjects that could achieve SpO2 ≥90% for >30% of sleep time
Secondary study objectives
Minimum/maximum SpO2 on initial setting and maximal setting
Number, duration, variability, and AUC of dips below 90% during sleep time on initial setting and maximal setting
Number/% of subjects requiring increased settings and the difference between initial and maximal settings required to meet target SpO2 ≥90% for >30% of sleep time criteria
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: InogenOne Rove 6 Portable Oxygen ConcentratorExperimental Treatment1 Intervention
InogenOne Rove 6 Portable Oxygen Concentrator
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
InogenOne Rove 6 Portable Oxygen Concentrator
2023
N/A
~20

Find a Location

Who is running the clinical trial?

Inogen Inc.Lead Sponsor
4 Previous Clinical Trials
189 Total Patients Enrolled
Stanislav Glezer, MDStudy ChairInogen Inc.
~9 spots leftby Dec 2025